These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18959739)

  • 1. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
    So WK; Cheng JC; Poon SL; Leung PC
    FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
    Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
    Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
    Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues.
    Cheung LW; Wong AS
    FEBS J; 2008 Nov; 275(22):5479-95. PubMed ID: 18959738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.
    Kraus S; Naor Z; Seger R
    Cancer Lett; 2006 Mar; 234(2):109-23. PubMed ID: 16546667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells.
    Sugiyama M; Imai A; Furui T; Tamaya T
    Oncol Rep; 2005 May; 13(5):813-7. PubMed ID: 15809743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
    Eicke N; Günthert AR; Emons G; Gründker C
    Int J Oncol; 2006 Nov; 29(5):1223-9. PubMed ID: 17016655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells.
    Imai A; Iida K; Furui T; Tamaya T
    Int J Oncol; 2002 May; 20(5):987-92. PubMed ID: 11956594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
    Naor Z
    Front Neuroendocrinol; 2009 Jan; 30(1):10-29. PubMed ID: 18708085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
    Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review).
    Sugiyama M; Imai A; Takahashi S; Hirano S; Furui T; Tamaya T
    Int J Oncol; 2003 Aug; 23(2):445-52. PubMed ID: 12851694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
    Günthert AR; Gründker C; Hollmann K; Emons G
    Biochem Biophys Res Commun; 2002 May; 294(1):11-5. PubMed ID: 12054733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of PER1 mRNA expression in immortalized gonadotropes by gonadotropin-releasing hormone (GnRH): involvement of protein kinase C and MAP kinase signaling.
    Olcese J; Sikes HE; Resuehr D
    Chronobiol Int; 2006; 23(1-2):143-50. PubMed ID: 16687288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.